rs4149056(C;C)
17x myopathy risk for statin users
- Magnitude
- 3.2Important
- Repute
- Bad
- Frequency
- 1%Average of 11 populations
- On SNPedia
- rs4149056(C;C)
- Gene
- SLCO1B1
Frequency
Share of people with C;C in each HapMap population.
- Tuscan4%
- Chinese (Denver)3%
- Japanese (Tokyo)3%
- Maasai (Kenya)2%
- African ancestry (Southwest US)2%
- Han Chinese (Beijing)2%
- European ancestry (Utah)<1%
- Yoruba (Nigeria)0%
- Gujarati Indian0%
- Luhya (Kenya)0%
- Mexican ancestry (Los Angeles)0%
Other genotypes of rs4149056
Notes
From SNPedia
reduced breakdown of some drugs; CPIC Recommendation: Prescribe a lower dose (20mg daily) or consider an alternative statin (e.g., pravastatin or rosuvastatin); consider routine creatine kinase (CK) surveillance. significantly associated with myopathy in patients who received simvastatin, but not in patients who received atorvastatin. PMID 21243006 however it did not affect pravastatin.
References
Related
Source and license
Adapted from rs4149056(C;C) on SNPedia, using a snapshot taken October 16, 2026. SNPedia content is shared under CC BY-NC-SA 3.0 US, and this page is shared under the same license.
SNPedia is a community-edited wiki. Its entries can be incomplete, out of date or wrong, and nothing here is a diagnosis or medical advice. Magnitude is a community rating of how interesting a genotype is, not a risk score.